Post by Elephas

Most preclinical models aren't failing because of bad science. They're failing because they don't capture how tumors actually respond to therapy. elive™ is designed to change that. The platform preserves intact, living tumor tissue and measures real-time immune response using a standard-of-care core needle biopsy, tracking longitudinal cytokine responses to predict how a tumor is likely to respond to immunotherapy. If you're working on IO programs and thinking about translation risk: https://lnkd.in/gFsw5StG #Elephas #TransformingOncologyDiagnostics #Immunotherapy #CancerResearch #Pharma #BioPharma #DrugDevelopment #BioTech